other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}

Adviser Profile

As of Date 10/09/2024
Adviser Type - Large advisory firm
Number of Employees 6 20.00%
of those in investment advisory functions 4 33.33%
Registration SEC, Approved, 08/01/2017
Other registrations (3)
AUM* 347,828,196 28.10%
of that, discretionary 347,828,196 28.10%
Private Fund GAV* 347,828,196 28.10%
Avg Account Size 347,828,196 28.10%
SMA’s No
Private Funds 1
Contact Info 541 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
272M 233M 194M 155M 116M 78M 39M
2017 2018 2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeHedge Fund Count1 GAV$347,828,196

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser GORDIAN WEALTH ADVISORS, LLC Hedge Fund14.2m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV14.2m AUM342.7m #Funds2
Adviser KRUSEN CAPITAL MANAGEMENT, LLC Hedge Fund60.6m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV60.6m AUM213.6m #Funds1
Adviser PHARVISION ADVISERS, LLC Hedge Fund80.0m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV80.0m AUM400.0m #Funds1
Adviser BENGAL ASSET MANAGEMENT, LLC Hedge Fund203.3m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV203.3m AUM203.3m #Funds1
Adviser NORCAP INVESTMENT MANAGEMENT, L.P. Hedge Fund204.4m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV204.4m AUM204.4m #Funds5
Adviser SPRUCE POINT CAPITAL MANAGEMENT, LLC Hedge Fund334.5m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV334.5m AUM334.5m #Funds1
Adviser ACM Hedge Fund2.6m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV2.6m AUM301.4m #Funds1
Adviser KNUFF & COMPANY LLC Hedge Fund8.0m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV8.0m AUM308.5m #Funds1
Adviser HARVEST MANAGEMENT, L.L.C. Hedge Fund74.6m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV74.6m AUM396.2m #Funds2
Adviser LIVELLO CAPITAL MANAGEMENT LP Hedge Fund218.6m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV218.6m AUM225.5m #Funds2

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker000899104 Stock NameADMA BIOLOGICS INC $ Position$37,381,300 % Position24.00% $ Change79.00% # Change0.00%
Stck Ticker30052C107 Stock NameEVOLUS INC $ Position$22,191,100 % Position14.00% $ Change23.00% # Change-17.00%
Stck Ticker36315X101 Stock NameGALAPAGOS NV $ Position$13,780,593 % Position9.00% $ Change15.00% # Change-1.00%
Stck TickerG50871105 Stock NameJAZZ PHARMACEUTICALS PLC US LISTED $ Position$6,127,550 % Position4.00% $ Change # Change
Stck TickerG7709Q104 Stock NameROYALTY PHARMA PLC $ Position$5,997,480 % Position4.00% $ Change # Change
Stck Ticker98419J206 Stock NameXOMA CORP $ Position$5,166,142 % Position3.00% $ Change-13.00% # Change-22.00%
Stck Ticker488445206 Stock NameZEVRA THERAPEUTICS INC $ Position$4,858,000 % Position3.00% $ Change # Change
Stck Ticker761330109 Stock NameREVANCE THERAPEUTICS INC $ Position$4,255,800 % Position3.00% $ Change-41.00% # Change-71.00%
Stck Ticker766559702 Stock NameRIGEL PHARMACEUTICALS INC $ Position$5,001,238 % Position3.00% $ Change99.00% # Change1.00%
Stck Ticker46333X108 Stock NameIRONWOOD PHARMACEUTICALS INC $ Position$4,120,000 % Position3.00% $ Change1216.00% # Change1983.00%

Brochure Summary

Overview

Stonepine is a Delaware limited liability company that has been in business since 2006. Jon M. Plexico and Timothy P. Lynch are Stonepine’s members, managers and are two of the portfolio managers of the Funds (defined below). As of December 31, 2023, Stonepine had total discretionary assets under management of approximately $336,517,620. Stonepine only manages assets on a discretionary basis. Stonepine serves as the investment adviser to Stonepine Capital, L.P., a private investment fund (“Stonepine Capital”) and its affiliate Stonepine GP, LLC serves as the general partner to Stonepine Capital. Stonepine may form additional private investment funds in the future, and it may form one or more “special purpose” funds (the “SPVs”) to invest in opportunities that it believes are attractive but are (a) outside
of Stonepine Capital’s investment strategy, or (b) are appropriate for Stonepine Capital, but too large to allocate solely to that fund, or (c) in Stonepine’s judgment not appropriate at that time for Stonepine Capital. Stonepine does not currently advise any SPVs. Stonepine Capital, any additional private investment fund that Stonepine may form in the future and any SPVs are referred to collectively as the “Funds” and individually as a “Fund”. Stonepine invests on the Funds’ behalf principally, but not solely, in equity and equity-related securities in healthcare companies that are traded publicly in U.S. markets, but is authorized to enter into any type of investment transaction that it deems appropriate under the terms of each Fund’s governing documents. Stonepine does not participate in wrap fee programs.